<HashMap><database>biostudies-literature</database><scores/><additional><submitter>Bocharnikov AV</submitter><funding>NIAMS</funding><funding>Rheumatology Research Foundation</funding><funding>Burroughs Wellcome Fund</funding><funding>Lupus Research Alliance</funding><funding>NIAMS NIH HHS</funding><pagination>130062</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC6824311</full_dataset_link><repository>biostudies-literature</repository><omics_type>Unknown</omics_type><volume>4(20)</volume><pubmed_abstract>Systemic lupus erythematosus (SLE) is an autoimmune disease characterized by pathologic T cell-B cell interactions and autoantibody production. Defining the T cell populations that drive B cell responses in SLE may enable design of therapies that specifically target pathologic cell subsets. Here, we evaluated the phenotypes of CD4+ T cells in the circulation of 52 SLE patients drawn from multiple cohorts and identified a highly expanded PD-1hiCXCR5-CD4+ T cell population. Cytometric, transcriptomic, and functional assays demonstrated that PD-1hiCXCR5-CD4+ T cells from SLE patients are T peripheral helper (Tph) cells, a CXCR5- T cell population that stimulates B cell responses via IL-21. The frequency of Tph cells, but not T follicular helper (Tfh) cells, correlated with both clinical disea</pubmed_abstract><journal>JCI insight</journal><pubmed_title>PD-1hiCXCR5- T peripheral helper cells promote B cell responses in lupus via MAF and IL-21.</pubmed_title><pmcid>PMC6824311</pmcid><funding_grant_id>Career Award in Medical Sciences</funding_grant_id><funding_grant_id>R01 AR065538</funding_grant_id><funding_grant_id>Scientist Development Award</funding_grant_id><funding_grant_id>UH2 AR067679</funding_grant_id><funding_grant_id>AR072791</funding_grant_id><funding_grant_id>AR065538</funding_grant_id><funding_grant_id>AR070253</funding_grant_id><funding_grant_id>P30 AR070253</funding_grant_id><funding_grant_id>K08 AR072791</funding_grant_id><funding_grant_id>Target Identification in Lupus</funding_grant_id><pubmed_authors>Wacleche VS</pubmed_authors><pubmed_authors>Wofsy D</pubmed_authors><pubmed_authors>Diamond B</pubmed_authors><pubmed_authors>Gurish MF</pubmed_authors><pubmed_authors>Petri M</pubmed_authors><pubmed_authors>Wang G</pubmed_authors><pubmed_authors>Guthridge JM</pubmed_authors><pubmed_authors>Li ZJ</pubmed_authors><pubmed_authors>Arazi A</pubmed_authors><pubmed_authors>Buyon JP</pubmed_authors><pubmed_authors>Keras G</pubmed_authors><pubmed_authors>Lederer JA</pubmed_authors><pubmed_authors>Muise ES</pubmed_authors><pubmed_authors>Qu Y</pubmed_authors><pubmed_authors>Accelerating Medicines Partnership (AMP) RA/SLE Network</pubmed_authors><pubmed_authors>Costenbader KH</pubmed_authors><pubmed_authors>James JA</pubmed_authors><pubmed_authors>Mackey MF</pubmed_authors><pubmed_authors>Rao DA</pubmed_authors><pubmed_authors>Anolik JH</pubmed_authors><pubmed_authors>Nigrovic PA</pubmed_authors><pubmed_authors>Fonseka CY</pubmed_authors><pubmed_authors>Keegan J</pubmed_authors><pubmed_authors>Zhang KX</pubmed_authors><pubmed_authors>Alves SE</pubmed_authors><pubmed_authors>Putterman C</pubmed_authors><pubmed_authors>Brenner MB</pubmed_authors><pubmed_authors>Cao Y</pubmed_authors><pubmed_authors>Bocharnikov AV</pubmed_authors></additional><is_claimable>false</is_claimable><name>PD-1hiCXCR5- T peripheral helper cells promote B cell responses in lupus via MAF and IL-21.</name><description>Systemic lupus erythematosus (SLE) is an autoimmune disease characterized by pathologic T cell-B cell interactions and autoantibody production. Defining the T cell populations that drive B cell responses in SLE may enable design of therapies that specifically target pathologic cell subsets. Here, we evaluated the phenotypes of CD4+ T cells in the circulation of 52 SLE patients drawn from multiple cohorts and identified a highly expanded PD-1hiCXCR5-CD4+ T cell population. Cytometric, transcriptomic, and functional assays demonstrated that PD-1hiCXCR5-CD4+ T cells from SLE patients are T peripheral helper (Tph) cells, a CXCR5- T cell population that stimulates B cell responses via IL-21. The frequency of Tph cells, but not T follicular helper (Tfh) cells, correlated with both clinical disea</description><dates><release>2019-01-01T00:00:00Z</release><publication>2019 Oct</publication><modification>2025-04-05T13:31:09.299Z</modification><creation>2019-11-15T08:04:51Z</creation></dates><accession>S-EPMC6824311</accession><cross_references><pubmed>31536480</pubmed><doi>10.1172/jci.insight.130062</doi></cross_references></HashMap>